| Returns | 1W : -2.7% , 1M : -4%,1Y : 32.7% |
| LT : |
Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued] Debt : Average |
| ST : |
Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward Pledged Shares : None or < 25% |
| Peers & Returns | 1W | 1M | 1Y |
| VENKYS (INDIA) | -2.7% | -4% | 32.7% |
| BOMBAY BURMAH TRADING CORPORATION | -4% | -1% | 37.9% |
| KAVERI SEED COMPANY | 8.2% | 15.6% | 51.5% |
| GOODRICKE GROUP | 0.5% | -10.4% | 37% |
| NATH BIOGENES (INDIA) | -4.8% | 7.1% | 47.3% |
| JK AGRI GENETICS | -5.4% | 2.6% | 35.5% |
| SHREE GANESH BIOTECH (INDIA) | -0.7% | -0.7% | -27.4% |
| DHUNSERI TEA & INDUSTRIES | 0.5% | -7% | 81% |
| HARRISONS MALAYALAM | -0.5% | -10% | 130.3% |
| Ratio | Value |
|---|---|
|
P/E P/B P/S |
-
P/E Calculated based on EPS of -19.28
[ Mar2020 - Standalone Results ] 2.57
P/B Calculated based on Book Value of 593.62
[ Mar2020 - Standalone Results ] 0.74
P/S Calculated based on Revenues of 2897.26 Cr
[ TTM - Standalone Results ] |
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
NA -14% 28% |
| Pledged Shares |
0 % |
|---|---|
| As on : Sep2020 | |
If less than 25% | Good |
| If between 25% and 50% | Neutral |
| If greater than 50% | Bad |
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE SMALL CAP | -0.1% | 0.3% | 91.4% |
| S&P BSE MIDSMALLCAP | -0.3% | -0.3% | 79.7% |
| S&P BSE 400 MIDSMALLCAP | -0.4% | -0.8% | 81% |
| S&P BSE 250 SMALLCAP | -1% | -2.2% | 88.2% |
| S&P BSE ALLCAP | -1.1% | -2.1% | 60% |
| S&P BSE 500 | -1.1% | -2.2% | 59.1% |
| S&P BSE FMCG | -1.3% | 3.5% | 16.1% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY MID SMALL400 | -0.7% | -1% | 81% |
| NIFTY SMALLCAP250 | -0.7% | -1.2% | 90.7% |
| NIFTY 500 | -1.1% | -2.2% | 58.6% |
